Skip to main content

Table 3 Cox regression analysis

From: A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma

Parameter tested p-value Hazard ratio [95% CI] (if relevant)
Age p = 0.1644
Body weight p = 0.4476
Gender p = 0.1750
 Female vs Male 1.163 [0.94; 1.45]
ECOG performance status p < 0.0001
 1: Restricted vs 0: Active 1.76 [1.42; 2.18]
 2: Self-care capable vs 0: Active 3.00 [2.13; 4.22]
 3: Limited self-care capable vs 0: Active 6.91 [3.64; 13.11]
 4: Disabled vs 0: Active 629.65 [56.44; 7024.33]
M Status p = 0.0005
 M1a vs M1c 0.54 [0.43; 0.81]
 M1b vs M1c 0.66 [0.36; 0.82]
Previous brain metastases p = 0.2622
 No vs Yes 0.88 [0.71; 1.10]
Treatment naive p = 0.0114
 No vs Yes 1.29 [1.06; 1.57]
Hospital p = 0.7601
 Private vs Public 0.965 [0.77; 1.21]
Community p = 0.5048
 Urban vs Rural 1.07 [0.88; 1.31]